WHO Europe urges countries to keep using AstraZeneca Covid-19 vaccine

WHO's European director Hans Kluge said that, at this point in time, the benefits of the AstraZeneca vaccine far outweigh its risks.

The benefits of AstraZeneca's Covid-19 vaccine far outweigh any risks, and countries across Europe should continue to use it to help save lives in the pandemic, the World Health Organization's European director Hans Kluge said on Thursday.

WHO Europe director Hans Kluge during a press conference. (AFP)

Kluge noted that Europe's medicines regulators are investigating a small number of cases of blood clots in the region that have prompted around a dozen EU governments to suspend us of the AstraZeneca shot.

"As of now, we do not know whether some or all of the conditions have been caused by the vaccine or by other coincidental factors," he said, adding: "At this point in time, however, the benefits of the AstraZeneca vaccine far outweigh its risks – and its use should continue, to save lives."